Combination Therapy of F8IL10 and Methotrexate in Rheumatoid Arthritis Patients
Status:
Completed
Trial end date:
2017-04-13
Target enrollment:
Participant gender:
Summary
Phase I, multicenter, open-label, dose escalation study to test the efficacy and safety of
F8IL10 and methotrexate when given as a combination in rheumatoid arthritis patients.